Bachem Holding AG (SWX:BANB)
Switzerland · Delayed Price · Currency is CHF 78.75
-2.30 (-2.84%)
Oct 1, 2026, 5:30 PM CET
Bachem Holding AG Market Cap
Bachem Holding AG has a market cap or net worth of 5.9 billion as of October 1, 2026. Its market cap has increased by 34.55% in one year.
Market Cap
5.90B
Enterprise Value
6.06B
Revenue
708.53M
Ranking
n/a
PE Ratio
39.70
Stock Price
78.75
ChartMarket Cap Chart
Since March 1, 1999, Bachem Holding AG's market cap has increased from 1.52B to 5.90B, an increase of 287.49%. That is a compound annual growth rate of 5.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 5.90B | 31.40% |
| Dec 30, 2025 | 4.49B | 3.45% |
| Dec 30, 2024 | 4.34B | -10.92% |
| Dec 29, 2023 | 4.87B | -17.25% |
| Dec 30, 2022 | 5.89B | -44.23% |
| Dec 30, 2021 | 10.56B | 90.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 1.19B |
| Basilea Pharmaceutica AG | 832.02M |
| Santhera Pharmaceuticals Holding AG | 231.01M |
| Newron Pharmaceuticals | 172.88M |
| BioVersys AG | 160.71M |
| Molecular Partners AG | 126.79M |
| Xlife Sciences AG | 56.28M |
| MindMaze Therapeutics Holding | 25.13M |